Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... from Copenhagen, Denmark, "We considered that a moderate reduction of the central blood volume (CBV) may activate the coagulation system. Lower body negative pressure (LBNP) is ... signifying that the increased thrombin generation did not cause further intravascular clot formation. The plasma pancreatic polypeptide level decreased (13 +/- 11 to 6 +/- 8 pmol ...
2009 NOV 24 ... another patent was issued for this technology as a tool in the development of vena cava blood clot filters. Other 2009 Edison Patent Award Winners include Alcatel-Lucent, ...
2009 NOV 23 ... patients. The following year, Dr. Ganz developed a new method for direct measurement of blood flow in humans. His measurement technique was then incorporated into the Swan-Ganz ... medical center in the U.S. to test this therapy in humans. Today, throughout the world, clot-dissolving therapy is the standard treatment for heart attack patients. ...
2009 NOV 23 ... Adverse Drug Event, Adverse Drug Reaction, Angiology, Arrhythmia, Atrial Fibrillation, Blood Clot, Bradycardia, Cardiology, Cardiovascular, Central Nervous System Disease, Clotting, ...
2009 NOV 9 ... treatment Having lymph nodes removed Having radiation therapy Having an infection or blood clot in the limb affected by cancer treatment Warning Signs Aching or heaviness ...
2009 NOV 9 ... to be announced in the first half of 2010." Keywords: Biotechnology, Blood Clot, Clinical Trial Research, Clotting, Coagulant, Coagulation, Cystic Fibrosis, Drug ...
2009 NOV 9 ... inhibition are thus increasingly used to trigger and monitor replacement therapy with blood products. In this study, we evaluated the effect of factor XIII inhibition and ... and platelet-inhibited whole blood thrombelastographic assay. Clotting time, clot formation maximum clot firmness, and clot lysis at 60 min were evaluated in triplicate. ...
2009 NOV 24 ... and allied fields the present paper discusses synthesis, characterization, and blood compatibility study of macroporous cryogels of PVA and haemoglobin," scientists in ... "The biocompatibility of the prepared cryogels was judged by in vitro methods of blood-clot formation, percent haemolysis and protein (BSA) adsorption."Bajpai and ...
2009 NOV 23 ... are prone to rupture, causing a release of cholesterol and cellular debris into the blood stream that often results in a clot that obstructs blood flow to the heart, thus causing ...
2009 NOV 16 ... reduced risk of developing venous thromboembolism (VTE)-a collective term for DVT (blood clot) and pulmonary embolism (PE)-than patients not on statin therapy. Furthermore, patients ...
2009 NOV 9 ... scientists in the United States report. "He had a spontaneously formed blood clot in his left anterior descending coronary artery. In the setting of hypo-albuminemia ...
2009 NOV 9 ... Blakely. During a vacation with his family this summer, Blakely suffered a blood clot, which led to the discovery of a cancerous tumor and the amputation of one of his legs, ...
